Carl Nathan
Cornell University
H-index: 150
North America-United States
Top articles of Carl Nathan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase | Science Advances | Amrita Singh Samantha Ottavi Inna Krieger Kyle Planck Andrew Perkowski | 2024/3/15 |
Neutrophil‐plasmacytoid dendritic cell interaction leads to production of type I IFN in response to Mycobacterium tuberculosis | European Journal of Immunology | Angela M Lee Paôline Laurent Carl F Nathan Franck J Barrat | 2024/3 |
Macrocyclic compounds as proteasome inhibitors | 2024/2/8 | ||
Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase | 2024/4/25 | ||
Dipeptides as inhibitors of human immunoproteasomes | 2024/1/30 | ||
Interferon-γ and infectious diseases: Lessons and prospects | Jean-Laurent Casanova John D MacMicking Carl F Nathan | 2024/4/19 | |
Expanded version of Table 3 from:“Interferon-Gamma and Infectious Diseases: Lessons and Prospects” | Jean-Laurent Casanova John D MacMicking Carl F Nathan | 2024 | |
Peptidomimetic proteasome inhibitors | 2023/8/22 | ||
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas | ACS Medicinal Chemistry Letters | Samantha Ottavi Kelin Li Jackson G Cacioppo Andrew J Perkowski Remya Ramesh | 2023/6/26 |
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance | Cell chemical biology | Wenhu Zhan Daqiang Li Shubha Bevkal Subramanyaswamy Yi Jing Liu Changmei Yang | 2023/5/18 |
Proteasome inhibitors and uses thereof | 2023/4/18 | ||
Structure–Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II | Journal of medicinal chemistry | Hao Zhang John Ginn Wenhu Zhan Annie Leung Yi J Liu | 2023/1/11 |
Mycobacterium tuberculosis as teacher | Nature Microbiology | Carl Nathan | 2023/9 |
Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions | ACS infectious diseases | Ben Gold Jun Zhang Landys Lopez Quezada Julia Roberts Yan Ling | 2022/2/22 |
Transcriptional biomarkers of differentially detectable Mycobacterium tuberculosis in patient sputum | Mbio | Kayvan Zainabadi Kohta Saito Saurabh Mishra Kathleen Frances Walsh Laurent Daniel Mathurin | 2022/12/20 |
In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas | Journal of Medicinal Chemistry | Samantha Ottavi Sarah M Scarry John Mosior Yan Ling Julia Roberts | 2022/1/19 |
Mayako Michino-Jeremie Vendome | JOURNAL OF MEDICINAL CHEMISTRY | Hao Zhang John Ginn Wenhu Zhan Yi J Liu Annie Leung | 2022/6/21 |
Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors | Journal of medicinal chemistry | Hao Zhang John Ginn Wenhu Zhan Yi J Liu Annie Leung | 2022/6/21 |
Nonresolving inflammation redux | Carl Nathan | 2022/4/12 | |
Dipeptidomimetics as inhibitors of human immunoproteasomes | 2022/3/17 |
